data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Arcus Biosciences
(NYSE:RCUS)
$28.595
0.005[0.02%]
Last update: 3:59PM
Day High/Low- - -
52 Week High/Low16.74 - 49.1
Open / Close- / -
Float / Outstanding50.9M / 71.7M
Vol / Avg.2.4K / 1.4M
Mkt Cap2.1B
P/E34.45
50d Avg. Price22.23
Div / Yield-
Payout Ratio-
EPS-0.96
Total Float50.9M

Arcus Biosciences (NYSE:RCUS), Quotes and News Summary

Arcus Biosciences (NYSE: RCUS)

Day High/Low- - -
52 Week High/Low16.74 - 49.1
Open / Close- / -
Float / Outstanding50.9M / 71.7M
Vol / Avg.2.4K / 1.4M
Mkt Cap2.1B
P/E34.45
50d Avg. Price22.23
Div / Yield-
Payout Ratio-
EPS-0.96
Total Float50.9M
Benzinga - May 12, 2022, 7:57AM
Benzinga - May 11, 2022, 10:37AM
Benzinga - May 10, 2022, 8:21AM
Benzinga - May 9, 2022, 4:26PM
Benzinga - Apr 14, 2022, 11:53AM
Benzinga - Apr 5, 2022, 7:33AM
Benzinga - Apr 4, 2022, 5:17PM
Benzinga - Feb 24, 2022, 11:25AM
Benzinga - Feb 23, 2022, 4:42PM
Benzinga - Jan 11, 2022, 5:44AM
Benzinga - Jan 10, 2022, 8:12AM
Benzinga - Dec 21, 2021, 4:36PM
Benzinga - Dec 14, 2021, 4:07PM
Sector: Health Care.Industry: Biotechnology
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.310-0.960 -0.6500
REV79.420M18.005M-61.415M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Arcus Biosciences Questions & Answers

Q
How do I buy Arcus Biosciences (RCUS) stock?
A

You can purchase shares of Arcus Biosciences (NYSE: RCUS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Arcus Biosciences's (RCUS) competitors?
Q
What is the target price for Arcus Biosciences (RCUS) stock?
A

The latest price target for Arcus Biosciences (NYSE: RCUS) was reported by Goldman Sachs on Thursday, May 12, 2022. The analyst firm set a price target for 28.00 expecting RCUS to fall to within 12 months (a possible -2.08% downside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Arcus Biosciences (RCUS)?
A

The stock price for Arcus Biosciences (NYSE: RCUS) is $28.595 last updated July 5, 2022, 7:59 PM UTC.

Q
Does Arcus Biosciences (RCUS) pay a dividend?
A

There are no upcoming dividends for Arcus Biosciences.

Q
When is Arcus Biosciences (NYSE:RCUS) reporting earnings?
A

Arcus Biosciences’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Arcus Biosciences (RCUS) going to split?
A

There is no upcoming split for Arcus Biosciences.

Q
What sector and industry does Arcus Biosciences (RCUS) operate in?
A

Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.